Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

4.95USD
15 Dec 2017
Change (% chg)

$-0.35 (-6.60%)
Prev Close
$5.30
Open
$5.30
Day's High
$5.30
Day's Low
$4.95
Volume
41,596
Avg. Vol
24,484
52-wk High
$9.80
52-wk Low
$4.20

Latest Key Developments (Source: Significant Developments)

Intec Pharma reports Q3 earnings per share $0.40
Wednesday, 15 Nov 2017 04:01pm EST 

Nov 15 (Reuters) - Intec Pharma Ltd :Intec Pharma reports third quarter 2017 operating and financial results.Intec Pharma Ltd - ‍basic and diluted loss per ordinary share of $0.40 for three months ended Sept 30 ​.  Full Article

Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma
Friday, 25 Aug 2017 10:30am EDT 

Aug 25 (Reuters) - Intec Pharma Ltd :Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing.  Full Article

Intec Pharma announces pricing of $50 mln public offering of ordinary shares
Wednesday, 16 Aug 2017 09:00am EDT 

Aug 16 (Reuters) - Intec Pharma Ltd :Intec Pharma announces pricing of $50.0 million public offering of ordinary shares.Intec Pharma Ltd - ‍Pricing of underwritten public offering of about 10.6 million of ordinary shares at a public offering price of $4.70 per ordinary share​.Intec Pharma Ltd - ‍Intends to use net proceeds from offering to fund its phase iii clinical trial for accordion pill Carbidopa/Levodopa​.  Full Article

Intec Pharma announces proposed public offering of ordinary shares
Tuesday, 15 Aug 2017 04:01pm EDT 

Aug 15 (Reuters) - Intec Pharma Ltd ::Intec Pharma announces proposed public offering of ordinary shares.Intec Pharma Ltd- ‍intends to use net proceeds from offering to fund its phase III clinical trial for accordion pill carbidopa/levodopa​.  Full Article

Intec Pharma reports financial results for the first half of 2017​
Wednesday, 9 Aug 2017 05:00pm EDT 

Aug 10 (Reuters) - Intec Pharma Ltd :Intec Pharma reports financial results for the first six months of 2017.Intec Pharma Ltd - qtrly ‍basic and diluted loss per ordinary share $0.18​.  Full Article

Intec Pharma reports clinical results from phase I trial of accordion pill for cannabinoid therapies
Thursday, 3 Aug 2017 07:00am EDT 

Aug 3 (Reuters) - Intec Pharma Ltd ::Intec Pharma reports clinical results from phase i trial of accordion pill for cannabinoid therapies.Intec Pharma Ltd - ‍study results showed that AP-CBD/THC had significant improvements in exposure of CBD and THC compared with sativex​.Intec Pharma- ‍formation of thc metabolites were meaningfully reduced, AP-CBD/THC found to be safe,well tolerated with no serious adverse events reported​.  Full Article

Intec Pharma Ltd appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as CEO
Monday, 10 Jul 2017 09:37am EDT 

July 10 (Reuters) - Intec Pharma Ltd ::Intec Pharma Ltd - Intec Pharma appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as chief executive officer‍​.Intec Pharma Ltd - meckler was named vice chairman of Intec Pharma board of directors in April 2017 and will continue in that role.Intec Pharma Ltd says Giora Carni to continue to serve on the company's board .  Full Article

Intec Pharma appoints Jeffrey Meckler as CEO
Monday, 10 Jul 2017 08:33am EDT 

July 10 (Reuters) - Intec Pharma Ltd ::Intec Pharma appoints U.S. Life Sciences executive and vice chairman Jeffrey A. Meckler as chief executive officer.Intec Pharma Ltd - ‍Giora Carni who has served as interim chief executive officer since May 2017, will continue to serve on company's board​.  Full Article

Intec Pharma Ltd files for mixed shelf of up to $100.0 mln
Tuesday, 6 Jun 2017 05:28pm EDT 

June 6 (Reuters) - Intec Pharma Ltd : :Intec Pharma Ltd files for mixed shelf of up to $100.0 million .  Full Article

Intec Pharma files for resale of 2.1 mln ordinary shares
Friday, 7 Apr 2017 08:05am EDT 

Intec Pharma Ltd : Intec Pharma Ltd files for resale of 2.1 million ordinary shares by selling shareholders - SEC filing Source: (http://bit.ly/2oItJCp) Further company coverage: [NTEC.TA] ((bangalore.newsroom@thomsonreuters.com;)).  Full Article

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results